Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared on LinkedIn:
”Super excited to see our review on VEXAS syndrome now out in The Lancet Group.
Since VEXAS was first discovered at The National Institutes of Health five years ago, we have developed a large multidisciplinary clinical program encompassing National Heart, Lung, and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) seeing patients in our combined hematology and rheumatology clinic and developing therapeutic strategies.
While progress has been made, there is much left learn and discover for our patients.
Alice Fike, Peter Grayson, Bhavisha Patel, Kaitlin Quinn, Benjamin Turturice”
Read the full article here.
Article: VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies
Authors: Emma Groarke, Benjamin Turturice, Bhavisha A. Patel, Kaitlin A. Quinn, Alice Fike, Peter C. Grayso
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 11:48A Century of VWD: Redefining Its Role Beyond Hemostasis
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026